Portfolio Update

Summary by AI BETAClose X

CT UK High Income Trust PLC reported its portfolio as of October 31, 2025, with HSBC, AstraZeneca, and Shell as its top three holdings, representing 7.55%, 6.54%, and 5.45% of the investment portfolio, respectively. The trust's investments are predominantly in the FTSE 100 at 77.23%, with 15.96% in the FTSE 250, 5.93% in non-index stocks, and 0.88% overseas. The net gearing for the trust stands at 12.61%.

Disclaimer*

CT UK High Income Trust PLC
28 November 2025
 

CT UK HIGH INCOME TRUST PLC

 

LEI: 213800B7D5D7RVZZPV45

 

All data as at 31 October 2025

 

This data will be available on the Company's website: ctukhighincome.co.uk

 

 

 

 

Top ten holdings

% of Investment Portfolio



HSBC

7.55

AstraZeneca

6.54

Shell

5.45

Rio Tinto

4.66

Rolls Royce

4.55

GSK

3.83

Imperial Brands

2.98

RELX

2.71

BAE Systems

2.61

Phoenix Group

2.58







 

 

 

Investment breakdown

% of Investment Portfolio



FTSE 100

77.23

FTSE 250

15.96

Non-Index

5.93

Overseas

0.88



Net Gearing

12.61%




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings